Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab.
暂无分享，去创建一个
Thomas S. Lin | M. Grever | J. Byrd | T. Shanafelt | N. Heerema | F. Awan | G. Lozanski | S. Geyer | N. Kay | D. Lucas | D. Jelinek | Wenting Wu | N. Leung | T. Call | Melanie E. Davis | C. Zent | C. Secreto | R. Tschumper | T. Lin